Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of NGAL on Palicalcitol Efficacy in SHPT
NCT05720273Phase 4Recruiting
- Start
- Apr 2023
- Primary completion
- Mar 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of paricalcitol in secondary hyperparathyroidism (SHPT). Started Apr 2023; status: recruiting.
02
Drugs
paricalcitol
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT05720273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05720273.